Compugen Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
CGEN
IL0010852080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
736.2 ILa | -0.51% | -12.80% | +7.01% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
Sales 2024 * | 37.9M 14.31B | Sales 2025 * | 35.29M 13.33B | Capitalization | 168M 63.57B |
---|---|---|---|---|---|
Net income 2024 * | -13M -4.91B | Net income 2025 * | -29M -10.95B | EV / Sales 2024 * | 4.44 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.77 x |
P/E ratio 2024 * |
-14.5
x | P/E ratio 2025 * |
-6.96
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | -0.51% | ||
1 week | -12.80% | ||
Current month | -21.12% | ||
1 month | -25.77% | ||
3 months | -4.00% | ||
6 months | +122.69% | ||
Current year | +7.01% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 736.2 | -0.51% | 118,012 |
24-04-17 | 740 | +0.61% | 86,262 |
24-04-16 | 735.5 | -9.18% | 195,181 |
24-04-15 | 809.8 | +2.20% | 112,576 |
24-04-14 | 792.4 | -6.15% | 38,312 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 18, 2024 at 10:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.82% | 41.35B | |
+42.55% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
-3.74% | 11.68B | |
+22.12% | 11.6B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- CGEN Stock
- CGEN Stock